We examined the effects of quinidine (5-20 FIM) on transmembrane action potentials and ionic currents of isolated canine ventricular myocytes. Collagenase treatment of canine ventricular tissue produced a yield of 40-60% healthy cells. Myocytes had normal resting and action potentials as measured using conventional microelectrodes. Quinidine decreased V M , amplitude, overshoot, and the duration of action potentials stimulated by passage of brief current pulses through the recording pipette. Recovery was complete after washout except that action potential duration was prolonged compared with control. A discontinuous single microelectrode voltage ("switch") clamp was used to measure ionic currents. Quinidine irreversibly reduced steady-state outward current as measured with three different voltage clamp protocols. Quinidine reversibhy decreased peak calcium current as well as the slowly inactivating and/or steady-state inward currents in the plateau voltage range, presumably both "late" sodium (tetrodotoxin-sensitive) and calcium (tetrodotoxin-insensitive) currents. The effect on calcium current showed both tonic and use-dependent block. Thus, quinidine has a multitude of actions on both inward and outward currents, which combine to produce the net effect of quinidine on action potential configuration. (Circulation Research 1988;62:324-337)
Q uinidine is one of the oldest and most commonly used antiarrhythmic agents and remains among the most effective drugs for control of ventricular arrhythmias. However, the cellular mechanisms by which quinidine exerts its therapeutic effects are not clearly established. Evidence indicates that quinidine inhibits the excitatory sodium current underlying the action potential upstroke. u The binding to and blockade of sodium channels is thought to occur preferentially with the open state of the sodium channel, and recovery from block occurs at a relatively slow rate. 3 " 5 A voltage-and rate-dependent depression of the maximum rate of depolarization (V^) of the action potential by quinidine provides experimental evidence for these hypotheses. 67 In cardiac Purkinje fibers, quinidine generally increases action potential duration measured during terminal repolarization. 89 This effect has been attributed to a decrease in the delayed outward potassium current, I X1 .'° In other studies, quinidine has been shown to decrease action potential duration," 12 possibly as a result of inhibition of the slowly inactivating and/or steady-state sodium "window" current. 51314 Quinidine produces effects on action potential characteristics of ventricular muscle similar to those obtained in Purkinje fibers. Most notably, action potential duration is either decreased or increased, an effect which may be dependent on the concentration of the drug."' 6 Quinidine has also been reported to cause a depression of the action potential plateau and/or an increase in the slope of phase 2. 91017 This'action is associated with a negative inotropic effect of quinidine. 18 " The slow inward or calcium current (l^ is an important determinant of the plateau and repolarization phases of the cardiac action potential and of the initiation and maintenance of contraction. 20 The basis for this depressant effect of quinidine on cardiac force may reside in the ability of high concentrations of quinidine to decrease the slow inward current. 13 -21 The aim of the present study was to define the ionic mechanism(s) by which quinidine produces such diverse effects on action potential configuration. We compared the effects of quinidine on the action potential characteristics of intact canine ventricular muscle and isolated canine ventricular myocytes in which the problems associated with external ion accumulation and depletion are minimized. Membrane ionic currents were measured directly in isolated ventricular myocytes using the discontinuous single microelectrode voltage clamp technique. 22 We examined the effects of quinidine on the slowly inactivating sodium current, the slow inward calcium current, and the outward potassium current.
Materials and Methods

Solutions and Drugs
Normal Tyrode's solution (mM): NaCl 135, KC15.4, CaCl 2 HEPES-Tyrode's solution (mM): NaCl 142, KC1 5.4, CaCl 2 1.8, MgCl 2 0.5, dextrose 5, HEPES 5, adjusted with NaOH to pH 7.4.
Calcium-free cardioplegia solution (mM): NaCl 10, KC1 60, MgCl 2 5, Na-pyruvate 5, taurine 20, dextrose 20, sucrose 100, EGTA 0.5, HEPES 5, adjusted with HC1 to pH 7.3.
Enzymatic digestion medium: NaCl 140 mM, KC1 5.4 mM, MgCl 2 1.5 mM, dextrose 5 mM, HEPES 5 mM, collagenase 0.25% (2.5 mg/ml, Worthington Type II, Freehold, New Jersey), albumin 0.2% (2 mg/ml, bovine albumin, Sigma, St. Louis, Missouri), adjusted with NaOH to pH 7.2.
KB medium: KC1 30 mM, KH 2 PO 4 10 mM, MgCl 2 5 mM, K^ATP 5 mM, taurine 15 mM, glutamic acid 70 mM, EGTA 0.5 mM, KOH 5.2 g/1, adjusted with KOH to pH 6.9.
Tetrodotoxin (TTX) and quinidine sulfate were obtained from Sigma. Stock solutions of both drugs were prepared at a concentration of 1 mM and appropriate amounts of the stock solutions were added to the HEPES-Tyrode's solution immediately prior to use.
Procedures for Intact Ventricular Muscle and Isolation of Single Myocytes
Adult mongrel dogs were anesthetized with sodium pentobarbital (40 mg/kg i.v.). The heart was quickly removed and rinsed in cold normal Tyrode's solution. Papillary muscles and trabeculae were dissected from the right ventricle and placed in cold oxygenated normal Tyrode's solution. These preparations were used in the studies of "intact" ventricular myocardium. A portion of myocardium was enzymatically dissociated using a procedure modified from that of Isenberg and Klockner. 23 A 2-3-cm block of apical myocardium was obtained by making a transverse incision through the apex of the heart. This ventricular tissue was dissected further into 1-mm 3 blocks, then placed in calcium-free cardioplegia solution at 25° C with gentle shaking for 10 minutes. Approximately 40 chunks were then incubated in 8 ml of enzyme medium in a plastic test tube at 37.5° C and continuously stirred with O 2 bubbling. After 15 minutes, the supernatant was removed carefully with a Pasteur pipette, transferred to a clean test tube, and centrifuged at 600 rpm for 3 minutes. The supernatant was discarded, and the pellet of isolated cells was washed three times with 8 ml of KB medium. After each wash, the tube was centrifuged and the supernatant was discarded. The isolated ventricular myocytes then were stored in KB medium at 5° C and were viable usually for 24 hours thereafter.
Electrophysiological Techniques
Intact ventricular muscle studies. Papillary muscles or ventricular trabeculae (2-3 mm diameter) were placed in a test chamber and superfused continuously with normal Tyrode's solution at a rate of 10 ml/min. The Tyrode's solution was gassed with 95% O 2 -5% ,CO 2 , the pH was 7.3, and the temperature was monitored and maintained at 37 ± 0.5° C. The muscles were stimulated at a constant rate of 1 Hz via a bipolar extracellular platinum-iridium electrode, which was insulated except at the tip. The electrodes were connected to a constant current source (model 850A, WPI, New Haven, Connecticut) which was triggered by a digital interval generator (model 830, WPI). Stimuli were depolarizing square wave pulses at 1 msec in duration with an intensity of 1.5 times threshold. Glass microelectrodes filled with 3 M KC1 and which had tip resistances of 10-30 Mfl were used to record transmembrane potential. The microelectrode was connected through a Ag-AgCl junction to the input of a high impedance capacitance-neutralizing amplifier (Picometrics 181, Instrumentation Laboratories, Boston, Massachusetts). Continuous single impalements were maintained throughout all experiments. A 30minute control period, during which no alterations of action potential parameters were noted, preceded the initiation of each experiment.
Isolated ventricular myocyte studies. The isolated ventricular myocytes were transferred to a glass bottom experimental chamber (12x25 mm) filled with HEPES-Tyrode's solution to a height of 2 mm. After the myocytes settled and attached to the bottom of the chamber, they were continuously superfused with preheated HEPES-Tyrode's solution with a pH of 7.4 at a rate of 1.5 ml/min. The temperature was monitored and maintained at 37° C. The experimental chamber was placed on the stage of an inverted microscope (Nikon Diaphot-TMD). The cells could be viewed either through the binocular eyepieces or on a closedcircuit video monitor (model FVM 95A, NEC) via a video camera (model TC2000, RCA) attached to the side camera port of the microscope. Transmembrane potentials were recorded by means of conventional glass microelectrodes that were filled with 3 M KC1 and had tip resistances of 35-55 Mil. The microelectrode was connected through a Ag-AgCl electrode to the headstage preamplifier (model HS-2L, gain = 0.1) of an operational amplifier with high input impedance and variable input capacitance neutralization (Axoclamp-2, Axon Instruments, Burlingame, California). The voltage drop across the microelectrode produced by current injection was compensated electronically with an active bridge circuit immediately before impalement of a cell. The experimental bath was grounded through a 3 M KC1 agar bridge and Ag-AgCl junction. The microelectrodes were positioned with Huxley micromanipulators at the cell surface and impalement of the cell was achieved by briefly (1 msec) increasing the input capacitance neutralization to cause oscillation. After establishing a stable microelectrode seal, the myocyte was lifted off the bottom of the chamber to allow complete superfusion of the cell. Action potentials were generated by passing current pulses of 1 msec in duration, and with an intensity of 1.2 times threshold, through the recording electrode.
General electrophysiological procedures. Voltage and current signals were displayed on a storage oscilloscope (model 5111 A, Tektronix) and were photographed intermittently during the experiment or were recorded on a strip chart recorder (model 220, Gould, Cleveland, Ohio). The voltage and current signals also were analyzed by a Norland 3001 digital waveform analysis system (sampling frequency, 2 kHz) that performed rapid on-line data measurement of the following: transmembrane maximum diastolic potential (MDP), action potential amplitude (APA), action potential overshoot (OS), action potential duration at 50% (APD W ) and 90% (ADPJ of repolarization, and the maximum rate of depolarization (dV/dt) of phase 0(V^). The transmembrane voltage signal was input to an electronic differentiator that had a linear response in the range of 100-1,000 V/sec to determine V,^ of the action potential. For each experimental condition, 5 or 10 measurements of the above parameters were averaged.
Voltage Clamp Experiments
Voltage clamp experiments were performed with the Axoclamp-2 in the discontinuous single-electrode voltage clamp (dSEVC) or "switch" clamp mode. In this mode, the tasks of voltage-recording and currentpassing are allocated to the same electrode; that is, time-sharing techniques are used to prevent interactions between the two tasks. 22 The cycling rate of the dSEVC was 4-5 kHz and the current signal was filtered with an upper cut-off frequency of 0.3 kHz.
In the first voltage clamp protocol, the steady-state membrane currents were measured using a slowly rising voltage ramp, similar to that used by Colatsky. 10 The membrane potential was held initially at -90 mV, then a 1.5-mV/sec, 80-mV depolarizing ramp was applied as the command signal for the voltage clamp ( Figure 4 ). Because the voltage is never held constant (i.e., it is very slowly increasing), this protocol does not provide a true measure of the absolute steady-state currents. Nevertheless, the current-voltage relations obtained with this protocol were virtually indistinguishable from those obtained at the end of 10-second long depolarizing clamp steps. The advantages of the ramp protocol were that it provided a complete currentvoltage relation over the range studied, it was obtained rapidly, and it was less damaging to the cells, especially at depolarized potentials. In other voltage clamp protocols, the membrane voltage was clamped at holding potential (V b ), then was step depolarized or hyperpolarized in 10-mV increments to various test potentials (V t ). The duration and frequency of the clamp steps were varied appropriately (see "Results").
A separate voltage clamp protocol was used to study the effect of quinidine on the "slow inward" or calcium current (IcJ. In these experiments, V h was -40 mV and depolarizing voltage clamp steps of 100 or 200 msec in duration were applied to various V, in 10-mV increments at frequencies of 0.5 to 3 Hz. At this holding potential the fast inward sodium current ( 1^ should be fully inactivated 1 a and the transient outward current (IJ should be almost completely inactivated. 24 Tetrodotoxin (TTX, 10-20 fiM) was added to the Tyrode's solution to block residual l^, and 4-aminopyridine (4-AP, 2 mM) was added to block 1^,. Barium chloride (5 mM) was added to block outward potassium current and to increase I c ,. 23 With these experimental conditions, we define the peak l^ as the earliest maximum inward current after a depolarizing voltage step from V h of -4 0 mV, and we recognize that 1) these conditions may not be sufficient to abolish other currents entirely; 2) the dSEVC limits our ability to accurately resolve fast current transients; and 3) since Ba 2+ is present, lî s a mixed ionic current and its kinetics may be altered.
Each experiment consisted of three experimental periods: a control period, a test period during which one concentration of quinidine was applied, and, when possible, a period after washout of the drug. Sufficient time was allowed to obtain a steady-state condition for drug action. When appropriate, between each experimental protocol, the cell was stimulated at a frequency of 1 Hz to monitor action potential characteristics. We studied the effects of quinidine on action potential characteristics at concentrations of 1.6 and 3.2 pig/ml (5 and 10 /xM), which is within the range of clinically useful plasma concentrations. 2 * Because of the small amplitude of the currents (<2 nA) measured and because quinidine at concentrations of 3.2 /u,g/ml (10 /u.M) or less often produced small changes in ionic currents (e.g., slowly inactivating sodium and calcium currents), we chose to use a standard quinidine concentration of 6.5 /Ag/ml (20 fiM) in most of the voltage clamp experiments. This concentration was intermediate as compared with that used in other voltage clamp studies (2-50 /i,g/ml). 510M
Advantages and Limitations of dSEVC Method
An essential goal of these experiments was to maintain the isolated myocytes in as normal a physiological state as possible for as long as possible in order to accurately assess the effect of the drug. Therefore, to avoid disruption of the intracellular biochemical and ionic environments, we chose to use the dSEVC method for monitoring transmembrane potential and ionic currents. Using this technique, myocytes remained stable for hours. Action potential characteristics and membrane currents were unchanged during 30-minute control periods and returned to control values after exposure to drugs that washed out completely. The stability of 1^ was crucial since rundown of this current is common when using a suction pipette technique.
One concern regarding the method of dSEVC or "switch" clamp is the adequacy of voltage control using a single microelectrode for both voltage measurements and current passage. Uniform voltage control was confirmed in three experiments with an independent microelectrode at a distant site in the cell. Figure 1 steady-state conditions there was excellent spatial voltage control. During the step to V, of 0 mV, the voltage at V^ was -3 mV, and it was achieved within a few milliseconds after initiation of the clamp step. Note that the V w trace was filtered at 100 Hz to eliminate noise from the switching amplifier, resulting in a slowed response time. Less deviation was recorded with smaller clamp steps. These results show that we obtained good voltage control within a few milliseconds even for large voltage clamp steps. Because of limitations in temporal voltage control, in part resulting from the duration of the capacitance charging process (~2 msec) inherent in the dSEVC technique, we restricted our measurement of transmembrane ionic current to times greater than 5 msec after initiation of a clamp step.
Results
Action Potential Studies
Intact ventricular muscle. Figure 2 demonstrates the effect of 10 /xM quinidine on the action potential configuration recorded from a dog papillary muscle. Three superimposed recordings are shown. Quinidine decreased the overshoot and the amplitude of the action potential without affecting the maximum diastolic potential. Quinidine also reduced plateau height, and shortened the action potential duration in the plateau range but prolonged terminal repolarization, and thereby producing a crossover of the control action potential. Plateau height and duration recovered after washout of quinidine, but the overall action potential duration actually increased beyond control. Quantitative data and statistical analysis for the effects of quinidine on ventricular muscle action potential parameters are presented in Table 1 . Quinidine produced a significant reduction in the maximum rate of depolarization of phase 0 ( V^) , which was reversed after washout of the drug. Quinidine increased APDj,, and APD,,,, and a further prolongation of the action potential was observed after washout of the drug.
Isolated ventricular myocytes. Figure 3 illustrates the effect of 5 /xM quinidine on the action potential configuration and WBa x of an isolated dog ventricular myocyte. Quinidine decreased action potential duration, overshoot, and V,^ without affecting the maximum diastolic potential. These effects were reversible after washout of quinidine. In addition, APD^ increased beyond the control value during the washout period. Quantitative data and statistical analysis of the effects of quinidine at concentrations of 5 and 10 /xM are presented in Table 2 . Quinidine at both concentrations significantly decreased the amplitude, overshoot, and V^ of the action potential but had no significant effect on the maximum diastolic potential. In contrast to the effect on papillary muscles, quinidine significantly decreased APD,,, and APD W . The effects of quinidine on the action potential were reversed after washout of the drug. However, the action potential was prolonged beyond the control duration in 7 of 12 experiments for which some period of washout was obtained, but overall, the effect was not statistically significant. When observed, the prolongation was maintained throughout the recorded washout period of at least 15 minutes and as long as 45 minutes ( Figures  3 and 4 ). This effect was greater after 10 /xM quinidine.
Effect on Steady-State Membrane Currents
The effects of quinidine (20 /xM) on the steady-state membrane currents were assessed in 10 experiments using the ramp clamp protocol. The results of a typical experiment are illustrated in Figures 4 and 5. The control current-voltage relation has a characteristic N shape with a region of inward rectification and negative slope and is similar to that obtained in intact ventricular (5) (6)t (5) Values are presented as the mean ± SEM and were compared using Student's paired / test. Individual observations are the average of 10 action potentials at a stimulation frequency of 1 Hz. MDP, maximum diastolic potential; OS, overshoot; AMP, amplitude; APD^ and APDQQ, action potential duration at 50% and 90% of repolarization, respectively; V^^, maximum upstroke velocity (dV/dt) of phase 0 of action potential. Numbers in parentheses equal the number of experiments. Washout values are after exoposure to 10 fiM quinidine. *p<0.05 and tp<0.01 compared with control. muscle. 28 At membrane voltages more negative than the resting potential (-74 mV in this example), quinidine shifted the net current in the outward direction, as manifested by a slight upward shift in the currentvoltage relation and a decrease in the holding current at -90 mV (Figures 4 and 7) . At membrane voltages between the resting potential and about -4 0 mV, quinidine shifted the net current in the inward direction, as indicated by a downward shift in the currentvoltage relation. Thus, slope conductance was decreased. In the plateau range of membrane potentials (-40 to 0 mV), quinidine shifted the net current in the outward direction. The net currents (nA, mean ± SEM, n = 1 0 ) at membrane potentials of -90, -50, and -10 mV for the control versus quinidine (20 /JLM) were -1 . 0 4 ± 0 . 1 6 vs. -0 . 8 7 ± 0 . 1 3 , 0.63±0.08 versus 0.44±0.07, and 0.17±0.03 versus 0.25±0.04, respectively. All comparisons were significantly different (p<0.01). Qualitatively similar effects were obtained with 5 and 10 /xM quinidine ( Figure 6 ). These results suggest that quinidine affects more than one membrane current. The effects negative to -40 mV were consistent with a decrease in the time-independent background K + conductance (I K] ). The outward shift in net current positive to -40 mV and the decrease in action potential duration, despite a reduction in I KI , suggested that quinidine decreased inward current(s) in this voltage range. Furthermore, the reduction in V^ of the action potential by quinidine suggested a significant decrease in the fast sodium current (I Na ), possibly extending to block of the slowly inactivating or steady-state sodium "window" current.
After washout of quinidine, the outward shift in net current positive to -40 mV was eliminated. However, the apparent effects on I K1 were not reversible after washout (Figures 4 and 5) , and the inward shift in the net current above -60 mV was exaggerated, especially in the negative slope region between -50 and -30 mV. This probably caused the prolongation of the action potential beyond the original control duration after washout of the drug (Figures 3 and 4 ; Table 2 ).
Effect on Time-Independent Background K + Conductance (I KI )
To examine the effect on I K ,, we used a voltage clamp protocol that was expected to cause a change only in the background current. We held the membrane potential (V h ) at -40 mV and applied hyperpolarizing clamp steps 500 msec in duration to various test potentials (V,= -5 0 to -110 mV) at a frequency of 0.5 Hz. Figure 6A shows a representative current-voltage relation. In the control, the holding current (IJ was slightly outward (0.3 nA) and hyperpolarizing clamp steps resulted in instantaneous changes in current that reached steady state within 10 msec. The steady-state current (I,,) became more inward with increasingly larger hyperpolarizations, and at membrane potentials less negative than -70 mV the current-voltage relation (7) 31.4±2.6 (7) 108.9 + 4.5 (7) 129.5±22.8 (7) 178.3±26.8 (7) 377.5±48.7 (6) Quinidine (10MM) -73.4± 1.8 (7) 22.0 + 3.6 (7)t 1OO.4±5.5 (7)t 104.9+16.1 (7)* 147.4±20.9 (7)* 212.5±47.5 (6) displayed inward rectification consistent with the known properties of I K1 . Quinidine decreased I,, to 0.2 nA and affected the current-voltage relation over this voltage range in a qualitatively identical manner to that obtained using the ramp clamp protocol in Figure 5 .
The effect on I K1 was not reversible after washout of quinidine for periods of up to 45 minutes. The same effects were observed in two additional experiments. Quinidine affects other ionic currents, for instance both inward sodium and calcium currents (see below), in a use-and frequency-dependent manner. Therefore, we tested whether or not the effect of quinidine on I K , displayed use-or frequency-dependence in three additional experiments. Once a complete current-voltage relation was obtained as in Figure 6A , we applied trains of 10 hyperpolarizing clamp steps to a given test potential (usually -100 mV) at various frequencies (0.1 to 1 Hz). Under these conditions, quinidine decreased I K1 to the same degree for a given test potential regardless of frequency or position or step number in the train. The effects for hyperpolarizing pulses were also independent of the holding potential, but quinidine inhibited the current in a dose-dependent manner (cf. top panel of Figure 6B ). A similar dose-dependent inhibition of I K1 occurred with depo-larizing clamp steps (bottom panel of Figure 6B ), but was also use-and frequency-independent.
Effect on Slowly Inactivating or Steady-State ("Window") Sodium Current
During the cardiac action potential, the flow of sodium (Na + ) current is not restricted to the initial fast phase of depolarization. Cardiac Purkinje cells possess a maintained component of TTX-sensitive Na + current, which is a slowly inactivating and/or noninactivating, steady-state "window" current. 5 " 14 We have demonstrated that this Na + current contributes substantially to maintaining the plateau and prolonging action potential duration in these isolated ventricular myocytes (J.A. Wasserstrom and J.J. Salata, manuscript in review).
We tested the hypothesis that quinidine reduces the slowly inactivating Na + current in 6 experiments. The V h was usually -90 mV and depolarizing steps of 5 seconds in duration were applied to various V, in 10-mV increments at a frequency of 0.05 Hz. Membrane currents were measured at various times (0.1, 0.25, 0.5, 1, and 5 seconds) during the voltage clamp step. The effect of quinidine or TTX alone or a combination of both drugs was studied to determine if quinidine
Control
Quinidine Washout 100 msec affects the TTX-sensitive Na + current during the plateau of the action potential. Figure 7A shows the effects of TTX alone and in combination with quinidine during depolarizing voltage clamp steps from -90 mV to -6 0 mV and -3 0 mV. TTX alone caused an outward shift in the current at both representative V t , especially at earlier times in the clamp steps, thereby eliminating the time-dependent outward shift in the current. Addition of quinidine decreased the holding current at -90 mV, shifted the current inward at -60 mV, and produced a further outward shift at -30 mV. The current-voltage relation for this experiment is plotted in Figure 7B . TTX alone shifted the currentvoltage relation in the outward direction in a manner similar to that observed previously by us (J.A. Wasserstrom and J.J. Salata, manuscript in review) and others. 313 The amplitude of the TTX-induced current shift was greater at earlier times ( < 1 second) and was smaller at later times in the clamp step. M This result indicates that TTX blocked a time-dependent inward current and confirms the presence of a TTX-sensitive Na + current during the plateau of the action potential in these ventricular myocytes. Addition of quinidine produced an inward shift in the current-voltage relation at potentials between -80 and -4 0 mV and an outward shift at potentials more negative than the resting potential of -83 mV (cf. change in holding current at -90 mV in top panel). These results were the same as those observed in the absence of TTX as described earlier. Quinidine produced a further outward shift beyond that produced by TTX at -30 mV and less negative potentials. At potentials less negative than -40 mV (i.e., in the plateau voltage range) the effects of quinidine on the 
FIGURE 6. Effect of quinidine on the time-independent background K* conductance or inward rectifier, l [r Panel A shows the current-voltage relation obtained using the voltage clamp protocol depicted in the inset. Steady-state current (1J was measured at
the end of the 500-msec clamp step. In this example, clamp steps were applied at a frequency of 0.5 Hz, but results obtained at other frequencies (0.1 to 1 Hz) were superimposable, indicating a lack of use-or frequency-dependence, even with duty cycles at I Hz. Panel B confirms the lack of use-and frequency-dependence using both hyperpolarizing and depolarizing clamp steps (inset), although there was a dose-dependent inhibition ofla at each test potential. The data were identical for the first and last test pulse in a train of 10 current-voltage relation relative to control were nearly identical in both the presence and absence of TTX ( Figures 5 and 7) . However, at less negative test potentials (> -30 mV), the amplitude of the outward current shift (i.e., the absolute change in current produced by quinidine in the presence of TTX) even at higher TTX concentrations (40 /u.M), was less than with quinidine alone. The quinidine-induced outward shift in the current-voltage relation at these potentials reversed after washout of the drug both in the absence and presence of TTX. Similar results were obtained in all six experiments of this type. These results indicate that part of the outward shift produced by quinidine at less negative membrane potentials was due to a reversible inhibition of the TTX-sensitive Na + current.
However, it appears that quinidine also reversibly affected another inward current, possibly the slow inward or calcium current.
Effect on Slow Inward or Calcium Current (I C J
The hypothesis that quinidine reduced I,-, was examined in a series of 8 experiments. Figure 8 shows an example of the effect of quinidine on the peak l^. Quinidine clearly reduced the peak l^ at all test potentials. A plot of the current-voltage relation for the peak Ic is presented in Figure 9 , which also illustrates this effect. Quinidine significantly reduced 1^ at test potentials between -10 and +30 mV. Notably, the effect of quinidine on 1^ reversed after washout of the drug, indicating that the effect of quinidine could not be attributed to rundown of Ic. 27 For comparison, in 3 experiments after the washout of quinidine, we assessed the effect of verapamil (5 /xM), which produced a much greater inhibition of l^. Additionally, in a few experiments, higher concentrations of verapamil (10 fiM) or D600 (5 fiM) or CdCl 2 (100 /xM) inhibited almost all detectable 1^ after 15 minutes of superfusion (not shown).
Calcium channel antagonists typically exhibit voltage-and use-dependent inhibition of I c ,. 29 We tested whether or not quinidine inhibits 1^ in a use-dependent fashion in another group of experiments. Trains of voltage clamp steps 200 msec in duration were applied from a V h of -4 0 mV to a V, of 0 mV at varying frequencies (0.5 to 3 Hz) and 1^ was monitored. Trains were 30 seconds in duration and a 60-second rest period was interposed between each train. Figure 10 compares the control current tracings with those obtained after 15 minutes of exposure at rest to 20 /iM quinidine. During control, the amplitude of the peak 1^, changed biphasically, first increasing slightly to an early maximum, then decreasing slowly thereafter. Both the incline and FIGURE 9 . Effect ofquinidine on the current-voltage relation for the peak calcium current. Plotted data are the mean ± SEM (n = 8) peak inward calcium currents (I,J at the various V, during control (10 yM tetrodotoxin, 5 mM BaCl 2 , 2 mM 4-aminopyridine), quinidine (20 yM) , and after washout of the drug. Comparison data for verapamil (5 /JLM) were obtained after washout of quinidine in 3 experiments. Peak current amplitudes were measured as the difference between the peak current and the current at the end of the 100-msec clamp step. Statistical significance determined by paired t test.
decline of the peak 1^ occurred more rapidly at higher frequencies.
In the presence ofquinidine, the first peak l^ of each train was reduced to the same degree. This tonic block occurred for the very first clamp step when applied after about 10 minutes of exposure at rest to quinidine and persisted even if the rest interval between trains was increased to as long as 3 minutes (not shown). More importantly, progressive reduction of the peak 1ô ccurred during the trains. The rate and degree of inhibition increased dramatically with increasing frequency. These results indicate that the inhibition of the peak Ic, by quinidine is also use-and frequencydependent (see also Figure 11 ).
Calcium current in cardiac cells exhibits a maintained "late" component which may be either slowly inactivating or non-inactivating steady-state Ic, 30 and which maintains the plateau of the action potential. In Figure 10 , the decay or inactivation of I^ was incomplete at the end of the 200-msec long clamp steps (cf., control at 1 Hz). The late I^ decreased progressively during the control trains, and the decline was faster at higher frequencies. Quinidine inhibited the late component of 1^, and the use-dependence of this effect appeared to be substantially greater than the effect on the peak 1^. In other words, the envelope of the late I^ declined more rapidly than that of the peak Ic, especially at higher frequencies. The arrows in Figure 10 highlight this effect by pointing to the moment at which the inhibition of the late 1& reached the holding current level. Clearly, at higher frequencies this degree of inhibition occurred much earlier. proximately a 15% tonic reduction (first postrest step) and a significant frequency-dependent inhibition of the peak Ic, (/• = ().85, p<0.01). A much larger tonic inhibition (55%) of the late l^ was observed and, overall, inhibition of this component increased slightly but not significantly with frequency (see "Discussion").
Discussion
Effects of Quinidine on K + Currents
Several investigators have recently reported a variety of actions of quinidine on outward K + currents. Quinidine decreased the time-dependent delayed rectifier (I XI ) in both rabbit 10 and sheep" Purkinje fibers, as evidenced by a decrease in the amplitude of the tail currents. Colatsky 10 also demonstrated that quinidine caused an inward shift of steady-state plateau currents as well as a decrease in holding current at a holding potential of -43 mV in rabbit Purkinje fibers. This might have indicated an effect on the background K + conductance, I K1 . In contrast, quinidine caused an outward shift of the steady-state current-voltage relation in sheep Purkinje fibers," particularly in the plateau voltage range. This latter effect may not be a direct action of quinidine on outward K + currents, but may result instead from 1) an action of quinidine to block slowly inactivating or steady-state "window" Na + and/or Ca 2+ currents in this voltage range (see below); 2) the anticholinergic action of quinidine that occurs in sheep Purkinje fibers and which is responsible for a shortening of the action potential in this tissue, an effect that is blocked by atropine (G.I. Sawicki, J.J. Salata, J.A. Wasserstrom, and M.E. Arnsdorf, unpublished observation); and 3) quinidine also blocks the transient outward current (4,) , which is largely carried by K + ions, in canine Purkinje fibers. 31 In the present study, although we looked for I X1 , we never found any evidence that the current existed in these cells. We were unable to observe tail currents previously defined as resulting from activation of a I X1 in the appropriate voltage range (data not shown). This may be the result of the fact that the current tails were too small for our system to resolve. Gintant et al 32 commonly measured tail currents with an amplitude of about 300 pA in isolated dog Purkinje cells, which is within the measurable range of our system. Instead, this current may be absent in canine ventricular myocytes.
We did find that quinidine profoundly decreased I K1 , an effect that was particularly apparent in voltage ranges negative to -40 mV. This resulted in a decrease in current on either side of the apparent reversal potential, and was more pronounced at very negative potentials (-110 mV), supporting the fact that the current affected by quinidine in this voltage range was the background K + current (I K1 ). The apparent reversal potential of the current blocked by quinidine is less negative than the estimated value of -85 mV for an extracellular K + concentration of 5.4 mM. This result may be due to the existence of a TTX-sensitive Na + current that is also blocked by quinidine at potentials as negative as -70 mV. The effect of quinidine was qualitatively the same when analyzed with three separate protocols: a voltage ramp and either depolarizing or hyperpolarizing pulses. With the latter two protocols, we demonstrated that the inhibition of I K| by quinidine was independent of voltage, use, and frequency of stimulation. Furthermore, the inhibition was dose-dependent and irreversible even after a period of washout (15-45 minutes) sufficient to allow full recovery of \ mMX of the action potential and other ionic currents (see below). Therefore, quinidine seems to have its primary direct action on I K1 .
Effects of Quinidine on I Na and Slowly Inactivating "Late" Na + Current
The suggestion that a Na + current exists during the plateau of the action potential initially came from the observation that TTX decreased the action potential duration of Purkinje fibers. 33 Since then, studies in Purkinje fibers have demonstrated not only a TTXsensitive, steady-state Na + window current 13 but also a slowly decaying component of the Na + current 14 that is also inhibited by quinidine and local anesthetic agents. 3 " A similar TTX-sensitive Na + current is also present in the plateau region of action potentials in these isolated dog ventricular myocytes (J.A. Wasserstrom and J.J. Salata, manuscript in review).
In the present study, we observed that quinidine has a potent reversible blocking action on V,^. Although the relation between V^ and 1^ may not be linear, 34 Vf ell by nearly 40% in the presence of quinidine (cf. Table 2 ). This finding strongly suggests that quinidine blocks Na + channels. ' We also showed evidence that quinidine might block the slowly inactivating or "window" Na + current that occurs in the plateau voltage range. Quinidine produced a significant timedependent outward shift of the current-voltage relation in the plateau voltage range (Figure 7) . The degree of this inhibition with quinidine was diminished in the presence of TTX, suggesting that part of the effect of quinidine was TTX-sensitive and carried through Na + channels. We used TTX doses that should have been sufficient to block virtually all Na + channel current. We also showed that part of quinidine's block of plateau currents was TTX-insensitive. This may represent an effect of quinidine on a slowly inactivating or steadystate "window" Ca 2+ current as described below. Because of the prominent actions of quinidine on Vâ s well as the TTX-sensitive plateau current, we conclude that quinidine indeed blocks Na + channel currents including the slowly inactivating and/or steady-state "window" Na + current. Our conclusion agrees with that of Carmeliet et al who showed also that the block of slowly inactivating Na + current by quinidine is highly use-dependent. 5 
"
Effects of Quinidine on Peak and Slowly Inactivating "Late" I Ca Several investigators have reported that quinidine decreases peak l^ in both frog atrium 21 and cat papillary muscle.' 3 This is thought to underlie the negative inotropic actions of quinidine. 1819 Two kinds of Ca 2+ current (channels) have been described in cardiac cells. 33 One is transient or quickly inactivating and activates at a relatively negative membrane potential. Another is long-lasting or slowly inactivating and activates at a more depolarized membrane potential. Evidence indicates that in ventricular cells only the latter type exists, 33 and only this current type was examined in the present study. We have demonstrated that quinidine reduces 1^ in dog ventricular myocytes. We recorded stable control 1^ for up to 30 minutes before exposure to quinidine and, furthermore, we observed that the inhibitory actions of quinidine on 1^, reversed nearly to control after washout. Thus, we did not find rundown of 1^ that is characteristic of similar measurements obtained using the suction pipet technique. During control pulse trains, the initial increase in 1^ after the first depolarizing steps probably reflects the activation of residual I,,,, which then fails to recover completely from inactivation with frequent repetitive steps. The subsequent gradual decline of 1t o a steady state during the control trains occurs more rapidly and to a greater extent at higher frequencies and is most likely due to incomplete recovery from inactivation of Ic, or modified gating as a result of increased intracellular C a . When inhibition of peak 1^ by quinidine was present, pauses of up to several minutes were not sufficient to eliminate block completely with these voltage clamp conditions. The first pulse following a pause in the train of clamp steps stUl showed significant block. We interpret this observation to indicate the presence of tonic block of 1^ by quinidine.
More importantly, use-dependent inhibition of I,-, by quinidine was revealed at stimulation frequencies of 1 Hz and higher (Figures 10 and 11) . Thus, the currentvoltage relation of Figure 9 , which was obtained at 1 Hz, contains both tonic and use-dependent components, both of which would have been invoked in the effect on the action potential. At higher stimulation frequencies ( > 1 Hz) the degree of inhibition of peak Ic, increased and therefore would play a larger role in the effect of quinidine on the cardiac action potential.
Our measurements of peak 1^ could be slightly distorted in the time to peak current as a result of the delay in the settling time of the dSEVC technique. Therefore, we limited our analysis to the effect of quinidine on the amplitude of the peak l^. Any errors arising from the dSEVC technique would tend to reduce the amplitude of the transients such as peak 1^ and, as a result, the inhibition of 1^ by quinidine, if anything, could be underestimated.
In addition to blocking peak 1&, quinidine also reduced a TTX-insensitive late inward current in the plateau voltage range. These experiments indicate that this action of quinidine is most likely due to blockade of a slowly inactivating or steady-state "window" Ca 2+ current. 30 The effect of quinidine on this late component of Ic, appeared to be both a component of tonic block as well as added block with use, especially at higher frequencies ( Figure 10 ). Because this late component of 4 . was usually very small (<0.1 nA) and difficult to resolve accurately, Figure 11 may be an underestimate of the frequency-dependence of the inhibition of the late I^ Furthermore, the data of Figure 11 were standardized at 15 seconds after initiation of the train, at which time the frequency-dependence of the effect may have reached a steady level ( Figure 10 ). In any event, the larger percent inhibition of the late l^ may reflect a greater voltage-dependent inhibition of this component of the current. This suggests that quinidine may have a higher affinity for the open or inactivated state of calcium channels or that the channels must be opened to allow the drug access to a block site within the channel.
Basis for Effect of Quinidine on Action Potentials of Intact Myocardium and Isolated Myocytes
The action potentials of isolated myocytes differed characteristically from those of intact myocardium as previously reported. M The V^ values were higher in the isolated myocytes (317 versus 236 V/sec). Since the maximum diastolic potentials were not different, the larger V^ of myocytes probably reflects the lack of electrotonic depression of this parameter resulting from the large current sink that exists in the intact myocardium. The isolated myocytes had a relatively negative plateau potential and prominent notch in the action potential. The depth of the notch increased as the frequency of stimulation was decreased. This observation may represent an unmasking of 1^, in the isolated myocytes. Alternatively, the amplitude or kinetics of Ic may be altered in the isolated myocytes, thus contributing to the negative shift of the plateau.
Quinidine produced parallel changes in the amplitude, overshoot, V^, and plateau level of the action potential of both intact myocardium and isolated myocytes. Interestingly, quinidine prolonged the terminal phase of repolarization of the action potential in intact myocardium, but shortened the action potential of the isolated myocytes. The action potentials were either prolonged further in the intact myocardium or became prolonged beyond the control duration in the isolated myocytes after washout of quinidine, an effect also observed in canine Purkinje fibers."
The finding that quinidine inhibits inward Ca 2+ and Na + currents as well as I KI provides a basis for understanding the effects of quinidine on action potential configuration. For example, reduced inward currents may explain the negative shift in plateau voltage that occurs with exposure to quinidine. In addition, the abbreviation of the action potential in the plateau region causes a crossing-over of the action potential ( Figure 2 ) in intact muscle and contributes to a shortening throughout the action potential in isolated myocytes. Although quinidine would be expected to prolong action potential duration because of its potent inhibitory effect oh steady-state outward K + current (presumably I K1 ), the actions of quinidine to inhibit these inward currents provide a counterbalance to the change in outward current that hastens repolarization in isolated myocytes.
The results in isolated myocytes are in contrast to the effects of quinidine in intact myocardium where quinidine prolongs terminal repolarization. Several explanations may be involved. First, it is possible that we are studying different cell types, one that occurs in the surface of the myocardium for intact preparations and another that is isolated from deep in the ventricular wall. 37 Second, the presence of restricted intercellular spaces endows multicellular preparations with certain inhomogeneities due to accumulation and depletion of extracellular ions to which isolated myocytes are largely not as susceptible. It is possible, therefore, that the decrease in K + conductance that occurs with quinidine causes a decrease in cleft K + accumulation, which has further direct effects on K + conductances.
An important new finding of this study is that the effect of quinidine on I K1 appeared to reverse very slowly or not at all after washout of the drug. This action is distinctly different from the effects on other ionic currents (e.g.,1^ and I Nl ) for which the effects are fully reversible. This finding provides a basis for the prolongation of action potential duration during washout of quinidine in this and other studies. 17 Roden and Hoffman 9 recently showed that quinidine produced a greater increase in APD W at lower frequencies. The frequency-dependent effects of quinidine on inward currents combined with the frequencyindependent effects on I K , provide a possible explanation for their observation. At low frequencies, the tonic inhibition of outward current(s) would predominate producing greater action potential prolongation. At higher frequencies, there would be a larger usedependent inhibition of the late inward currents, both Na + and Ca 2+ , which would counterbalance and diminish the tonic action potential prolonging effect due to a frequency-independent inhibition of I K , and possibly I XI . Quinidine might have additional frequency-dependent effects on action potential duration through inhibition of 1^, depending on the kinetics of block of this current. These hypotheses require further study.
While this paper was in review, a similar study by Hiraoka et al 38 was published. In isolated guinea pig ventricular myocytes, quinidine prolonged action potential duration of myocytes stimulated at a frequency of 0.1 Hz. From voltage clamp experiments, they concluded that quinidine inhibited the delayed outward K + current (I x , or I K , reversibly), the inward rectifier (I K1 , irreversibly), and peak calcium current (1^, reversibly). They also concluded that there was no effect'of quinidine on the steady-state "window" Na + current, but they did not look for slowly inactivating Na + current, specifically.
